Pharmaron and AstraZeneca Enter Sweeping Partnership to Span Drug Development Services
Pharmaron Beijing Co., Ltd, a leading Contract Research Organization (CRO) based in Beijing (HKG: 3759;...
Deals
Union Hospital Teams Up with Baidu Health for AI-Enhanced Outpatient Services
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, has entered into a...
Pharmaron to Sell Proteologix Stake in Upcoming Johnson & Johnson Acquisition
Pharmaron Beijing Co., Ltd, a leading Contract Research Organization (CRO) based in Beijing (HKG: 3759;...
Fosun Pharma Nods to Fosun Health Spin-Off; IPO Venue and Requirements Under Review
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196), a leading pharmaceutical company in...
Zhejiang Huahai Pharmaceutical Co., Ltd Plans Capital Raise for Digital Manufacturing Expansion
Zhejiang Huahai Pharmaceutical Co., Ltd (SHA: 600521), a leading Chinese pharmaceutical company, has unveiled plans...
Porton Biologics and SAFE Collaborate to Accelerate Pharmaceutical R&D Services
Suzhou Porton Biologics Ltd, a China-based Contract Development and Manufacturing Organization (CDMO), has entered into...
Biocytogen Expands Reach to India with GVSAP Partnership for BioMice Models
A recent stock exchange announcement from China-based Biocytogen (HKG: 2315) has highlighted a strategic partnership...
Sol-Gel Technologies Partners with Shenzhen Beimei for Twyneo Commercialization in China
Israel-based dermatology specialist Sol-Gel Technologies Ltd. (NASDAQ: SLGL) has announced the signing of a licensing...
J&J Acquires Immune-Mediated Diseases Specialist Proteologix in a Deal Worth Up to USD 850 Million
Johnson & Johnson (J&J; NYSE: JNJ), a global healthcare giant, has announced a deal to...
Huaixi Medical and Beijing HumaDX Tech Join Forces to Boost In Vitro Diagnostics
Huaixi Medical, a Nanjing-based specialist in flow cytometry, has entered into a strategic partnership with...
Merck KGaA Subsidiary Teams Up with Aulos Bioscience to Test PD-L1 and Anti-IL-2 Combination
Germany’s Merck KGaA (ETR: MRK) has announced that its Switzerland-based subsidiary, Ares Trading, has entered...
Hengrui Pharmaceuticals Strikes Deal with Hercules CM Newco to Supply GLP-1 Products for Global Markets
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276), a leading Chinese pharmaceutical company, has entered into...
Novo Holdings Gains Controlling Interest in Biopharma Equipment Supplier Single Use Support
Novo Nordisk’s (CPH: NOVO-B) controlling shareholder, Novo Holdings, has entered into an agreement to purchase...
AstraZeneca and BenevolentAI Reach Milestone in Heart Failure Target Validation
AstraZeneca (AZ; NASDAQ: AZN) has announced the successful experimental validation of a groundbreaking heart failure...
Sunho Biologics Lists on HKEX with HKD 461 Million Biotech IPO
Sunho Biologics, Inc., (HKG: 2898) a clinical-stage biopharmaceutical company based in China specializing in biologic...
GE HealthCare Partners with Shanghai Pudong for USD 52.5 Million Medical Tech Investment
GE HealthCare (NASDAQ: GEHC), a leading medical technology firm, has entered into a cooperation intent...
Vision Medicals Raises Hundreds of Millions in Series D+ Round to Advance Molecular Diagnostics
Guangdong-based Vision Medicals has reportedly secured hundreds of millions of renminbi in a Series D+...
Nabla Bio Forges Partnerships with Top Pharma Companies to Tackle Challenging Drug Targets
Protein design specialist Nabla Bio has announced strategic collaborations with pharmaceutical giants AstraZeneca (AZ; NASDAQ:...
Eli Lilly & Co. Expands Clinical Collaboration with Shanghai East Hospital in China
Eli Lilly & Co. (NYSE: LLY), a leading global pharmaceutical company, has announced an expansion...
Elite (Suzhou) Analytical Instruments Boosts Liquid Chromatography Push with Series A+ Round
China-based Elite (Suzhou) Analytical Instruments Co., Ltd, a premier manufacturer of liquid chromatography devices in...